HeartSciences Inc. Total Assets
HeartSciences Inc. total assets. Based on the latest financial reports, HeartSciences Inc. (HSCS) holds total assets worth $3.74 Million USD as of July 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see HeartSciences Inc. market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of HeartSciences Inc. (2020–2026)
Total assets of HeartSciences Inc. from 2020 to 2026. This chart illustrates how HeartSciences Inc.'s total assets have evolved over time, based on quarterly financial data. See latest HeartSciences Inc. stock price today for real-time trading data and today's change.
HeartSciences Inc. - Asset Composition Analysis
HeartSciences Inc. Total Assets Breakdown (April 2026)
HeartSciences Inc. total assets breakdown as of April 2026. HeartSciences Inc.'s total assets of $3.74 Million consist of 49.1% current assets and 50.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 31.5% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $655.63 Million | 12.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.37 Billion | 45.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2026)
This chart illustrates how HeartSciences Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is HeartSciences Inc.'s working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: HeartSciences Inc.'s current assets represent 49.1% of total assets in 2026, a decrease from 78.6% in 2020.
- Cash Position: Cash and equivalents constituted 31.5% of total assets in 2026, up from 25.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 45.1% of total assets.
HeartSciences Inc. Competitors by Total Assets
Key competitors of HeartSciences Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Siemens Healthineers AG
F:SHL
|
Germany | €46.71 Billion |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.42 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.81 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.25 Billion |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$21.12 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
HeartSciences Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.12 | 1.47 | 1.47 |
| Quick Ratio | -71.42 | 1.25 | 0.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-4.95 Million | $1.40 Million | $524.28K |
HeartSciences Inc. - Advanced Valuation Insights
This section examines the relationship between HeartSciences Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 70.85 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 124522.0% |
| Total Assets | $5.26 Billion |
| Market Capitalization | $10.56 Million USD |
Valuation Analysis
Below Book Valuation: The market values HeartSciences Inc.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: HeartSciences Inc.'s assets grew by 124522.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for HeartSciences Inc. (2020–2026)
The table below shows the annual total assets of HeartSciences Inc. from 2020 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-04-30 | $5.26 Billion | +124521.98% |
| 2025-04-30 | $4.22 Million | -55.56% |
| 2024-04-30 | $9.50 Million | +189.09% |
| 2023-04-30 | $3.29 Million | +57.33% |
| 2022-04-30 | $2.09 Million | +8.41% |
| 2021-04-30 | $1.93 Million | -1.46% |
| 2020-04-30 | $1.96 Million | -- |
About HeartSciences Inc.
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related… Read more